Sébastien Fischman
Sébastien Fischman has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Mariano Suppa
Department of Dermatology, Hôpital Erasme (HUB), Université Libre de Bruxelles, 1070 Brussels, Belgium
2 shared publications - Arnaud Dubois
DAMAE Medical, Paris, France
1 shared publication Carmen Orte Cano
Department of Dermatology, Hôpital Erasme, HUB, Université Libre de Bruxelles, Brussels, Belgium
1 shared publicationClara Tavernier
DAMAE Medical, Paris, France
1 shared publication- Clara Tavernier
DAMAE Medical, 75013 Paris, France
1 shared publication - Clément Lenoir
Universitat de Barcelona
1 shared publication
Latest Publications
- 23 December 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
Response to Gao et al. on AI ‐assisted LC ‐ OCT for BCC diagnosis
- 23 December 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
Response to Gao et al. on AI ‐assisted LC ‐ OCT for BCC diagnosis
- Top Cited PapersOpen Access
- 19 October 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6) , 1059-1068
AI ‐assisted basal cell carcinoma diagnosis with LC ‐ OCT : A multicentric retrospective study
Background: Basal cell carcinoma (BCC) is the most common skin cancer, requiring an early diagnosis and accurate margin definition to prevent functional and cosmetic complications. Traditional methods using clinical and dermoscopic images (C&D) often rely on biopsies and histology for final validation. Non‐invasive techniques like LC‐OCT, enabling ‘digital biopsies’, are promising alternatives, but remain underutilized due to the expertise required. The development of Artificial Intelligence (AI) algorithms is a promising approach to assist dermatologists in their diagnosis and support the broader adoption of such technologies. Objectives: We present a real‐time AI assistant for BCC diagnosis with LC‐OCT, which is, to date, the only real‐time AI model across all dermatological imaging modalities. The study aims to quantify the model's effectiveness when used by dermatologists with different levels of expertise and compare its performance with traditional methods and unaided LC‐OCT. Methods: This multicenter, retrospective study involved 43 dermatologists in a double‐rounded quiz on 200 equivocal BCC lesions. Diagnoses were first made on C&D images, then with LC‐OCT or AI‐assisted LC‐OCT in a randomized manner. Results: AI‐assisted LC‐OCT significantly improves dermatologists' diagnostic performance in detecting BCC (+25.8 points in sensitivity and +16.8 points in specificity compared to C&D), particularly benefiting those with less LC‐OCT experience, effectively bridging a 2‐year gap of expertise. These results highlight the potential for broader clinical adoption through AI assistance and underscore its promise in reducing the need for invasive procedures and improving patient outcomes. Conclusions: These results support a broader adoption of LC‐OCT use in clinical practice thanks to AI assistance and underscore its promise in reducing the need for invasive procedures and improving patient outcomes.
- 19 October 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6) , 1059-1068
Top Cited PapersOpen AccessAI ‐assisted basal cell carcinoma diagnosis with LC ‐ OCT : A multicentric retrospective study
Background: Basal cell carcinoma (BCC) is the most common skin cancer, requiring an early diagnosis and accurate margin definition to prevent functional and cosmetic complications. Traditional methods using clinical and dermoscopic images (C&D) often rely on biopsies and histology for final validation. Non‐invasive techniques like LC‐OCT, enabling ‘digital biopsies’, are promising alternatives, but remain underutilized due to the expertise required. The development of Artificial Intelligence (AI) algorithms is a promising approach to assist dermatologists in their diagnosis and support the broader adoption of such technologies. Objectives: We present a real‐time AI assistant for BCC diagnosis with LC‐OCT, which is, to date, the only real‐time AI model across all dermatological imaging modalities. The study aims to quantify the model's effectiveness when used by dermatologists with different levels of expertise and compare its performance with traditional methods and unaided LC‐OCT. Methods: This multicenter, retrospective study involved 43 dermatologists in a double‐rounded quiz on 200 equivocal BCC lesions. Diagnoses were first made on C&D images, then with LC‐OCT or AI‐assisted LC‐OCT in a randomized manner. Results: AI‐assisted LC‐OCT significantly improves dermatologists' diagnostic performance in detecting BCC (+25.8 points in sensitivity and +16.8 points in specificity compared to C&D), particularly benefiting those with less LC‐OCT experience, effectively bridging a 2‐year gap of expertise. These results highlight the potential for broader clinical adoption through AI assistance and underscore its promise in reducing the need for invasive procedures and improving patient outcomes. Conclusions: These results support a broader adoption of LC‐OCT use in clinical practice thanks to AI assistance and underscore its promise in reducing the need for invasive procedures and improving patient outcomes.
- Top Cited PapersOpen Access
Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Skin Imaging in Dermatology
Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive optical imaging technique based on a combination of the principles of optical coherence tomography and reflectance confocal microscopy with line-field illumination, which can generate cell-resolved images of the skin in vivo. This article reports on the LC-OCT technique and its application in dermatology. The principle of the technique is described, and the latest technological innovations are presented. The technology has been miniaturized to fit within an ergonomic handheld probe, allowing for the easy access of any skin area on the body. The performance of the LC-OCT device in terms of resolution, field of view, and acquisition speed is reported. The use of LC-OCT in dermatology for the non-invasive detection, characterization, and therapeutic follow-up of various skin pathologies is discussed. Benign and malignant melanocytic lesions, non-melanocytic skin tumors, such as basal cell carcinoma, squamous cell carcinoma and actinic keratosis, and inflammatory and infectious skin conditions are considered. Dedicated deep learning algorithms have been developed for assisting in the analysis of LC-OCT images of skin lesions.
Top Cited PapersOpen AccessLine-Field Confocal Optical Coherence Tomography (LC-OCT) for Skin Imaging in Dermatology
Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive optical imaging technique based on a combination of the principles of optical coherence tomography and reflectance confocal microscopy with line-field illumination, which can generate cell-resolved images of the skin in vivo. This article reports on the LC-OCT technique and its application in dermatology. The principle of the technique is described, and the latest technological innovations are presented. The technology has been miniaturized to fit within an ergonomic handheld probe, allowing for the easy access of any skin area on the body. The performance of the LC-OCT device in terms of resolution, field of view, and acquisition speed is reported. The use of LC-OCT in dermatology for the non-invasive detection, characterization, and therapeutic follow-up of various skin pathologies is discussed. Benign and malignant melanocytic lesions, non-melanocytic skin tumors, such as basal cell carcinoma, squamous cell carcinoma and actinic keratosis, and inflammatory and infectious skin conditions are considered. Dedicated deep learning algorithms have been developed for assisting in the analysis of LC-OCT images of skin lesions.